The Bipolar Disorder Market report points out national and global business prospects and competitive conditions for bipolar disorder. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for bipolar disorder. The bipolar disorder market has been segmented by drug class (mood stabilizer, anticonvulsant, antipsychotic, antidepressant, antianxiety), and mechanism of action (selective serotonin reuptake inhibitor, serotonin norepinephrine reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors, benzodiazepines, beta blockers). Historical background for the demand of bipolar disorder has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand bipolar disorder have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Market Segmentation:

By Drug Class:

• Mood stabilizer
• Anticonvulsant
• Antipsychotic
• Antidepressant
• Antianxiety

By Mechanism of Action:

• Selective Serotonin Reuptake Inhibitor
• Serotonin Norepinephrine Reuptake Inhibitors
• Tricyclic Antidepressants
• Monoamine Oxidase Inhibitors
• Benzodiazepines
• Beta Blockers

By Region:

North America Bipolar Disorder Market

• North America, by Country
  • US
  • Canada
  • Mexico
• North America, by Drug Class
• North America, by Mechanism of Action

Europe Bipolar Disorder Market

• Europe, by Country
  • Germany
  • Russia
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Rest of Europe 
• Europe, by Drug Class
• Europe, by Mechanism of Action

Asia Pacific Bipolar Disorder Market

• Asia Pacific, by Country
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Rest of Asia Pacific 
• Asia Pacific, by Drug Class
• Asia Pacific, by Mechanism of Action

Middle East & Africa Bipolar Disorder Market

• Middle East & Africa, by Country 
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa
• Middle East & Africa, by Drug Class
• Middle East & Africa, by Mechanism of Action

South America Bipolar Disorder Market

• South America, by Country 
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
• South America, by Drug Class
• South America, by Mechanism of Action

Major Companies: Glaxo SmithKline (GSK), Pfizer Inc., Janssen Pharmaceuticals, Eli Lilly, Allergan Plc., Novartis AG, AbbVie Inc., Otsuka Holdings Co. Ltd, and AstraZeneca.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Objectives of this report:

• To estimate market size for bipolar disorder market on regional and global basis.
• To identify major segments in bipolar disorder market and evaluate their market shares and demand.
• To provide a competitive scenario for the bipolar disorder market with major developments observed by key companies in the historic years.
• To evaluate key factors governing the dynamics of bipolar disorder market with their potential gravity during the forecast period.

Reasons to Buy This Report:

• Provides niche insights for decision about every possible segment helping in strategic decision making process.
• Market size estimation of the bipolar disorder market on a regional and global basis.
• A unique research design for market size estimation and forecast.
• Identification of major companies operating in the market with related developments
• Exhaustive scope to cover all the possible segments helping every stakeholder in the bipolar disorder

Customization:

This study is customized to meet your specific requirements:

• By Segment
• By Sub-segment
• By Region/Country
• Product Specific Competitive Analysis

For more information, contact: [email protected]